We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
New Therapy Targets Resistant Non-Small-Cell Lung Cancers.
- Authors
Jenks, Susan
- Abstract
The article discusses a study published online on July 29, 2014 in the periodical "Cancer Discovery" which found that a combination of the drugs afatinib and cetuximab may benefit patients with advanced non-small-cell lung cancer (NSCLC). Topics discussed include the difference between afatinib-cetuximab drug combination and other similar compounds, the planned confirmatory trials of afatinib and cetuximab, and comments from Dr. Martin Edelman on drug regimen's short-lived benefit.
- Subjects
COMBINATION drug therapy; CETUXIMAB; CANCER treatment; NON-small-cell lung carcinoma; EDELMAN, Martin; DRUG efficacy; THERAPEUTICS
- Publication
JNCI: Journal of the National Cancer Institute, 2014, Vol 106, Issue 11, p1
- ISSN
0027-8874
- Publication type
Article
- DOI
10.1093/jnci/dju393